These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 31060822)
1. Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom. Donnelly DW; Gavin A; Downing A; Hounsome L; Kearney T; McNair E; Allan D; Huws DW; Wright P; Selby PJ; Kind P; Watson E; Wagland R; Wilding S; Butcher H; Mottram R; Allen M; McSorley O; Sharp L; Mason MD; Cross WR; Catto JWF; Glaser AW Eur Urol; 2019 Aug; 76(2):228-237. PubMed ID: 31060822 [TBL] [Abstract][Full Text] [Related]
2. Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study. Donnelly DW; Vis LC; Kearney T; Sharp L; Bennett D; Wilding S; Downing A; Wright P; Watson E; Wagland R; Cross WR; Mason MD; Siesling S; van Manen JG; Glaser AW; Gavin A BMC Cancer; 2019 Oct; 19(1):947. PubMed ID: 31615476 [TBL] [Abstract][Full Text] [Related]
3. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Downing A; Wright P; Hounsome L; Selby P; Wilding S; Watson E; Wagland R; Kind P; Donnelly DW; Butcher H; Catto JWF; Cross W; Mason M; Sharp L; Weller D; Velikova G; McCaughan E; Mottram R; Allen M; Kearney T; McSorley O; Huws DW; Brewster DH; McNair E; Gavin A; Glaser AW Lancet Oncol; 2019 Mar; 20(3):436-447. PubMed ID: 30713036 [TBL] [Abstract][Full Text] [Related]
4. Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study. Gavin AT; Donnelly D; Donnelly C; Drummond FJ; Morgan E; Gormley GJ; Sharp L BMJ Open; 2016 Dec; 6(12):e012952. PubMed ID: 27993906 [TBL] [Abstract][Full Text] [Related]
5. Urinary, bowel and sexual health in older men from Northern Ireland. Donnelly DW; Donnelly C; Kearney T; Weller D; Sharp L; Downing A; Wilding S; Wright P; Kind P; Catto JWF; Cross WR; Mason MD; McCaughan E; Wagland R; Watson E; Mottram R; Allen M; Butcher H; Hounsome L; Selby P; Huws D; Brewster DH; McNair E; Rivas C; Nayoan J; Horton M; Matheson L; Glaser AW; Gavin A BJU Int; 2018 Nov; 122(5):845-857. PubMed ID: 29489050 [TBL] [Abstract][Full Text] [Related]
6. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study. Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540 [TBL] [Abstract][Full Text] [Related]
7. Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment. Resnick MJ; Barocas DA; Morgans AK; Phillips SE; Chen VW; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hoffman KE; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Koyama T; Penson DF Cancer; 2014 Apr; 120(8):1263-71. PubMed ID: 24510400 [TBL] [Abstract][Full Text] [Related]
8. Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up. Watson E; Shinkins B; Frith E; Neal D; Hamdy F; Walter F; Weller D; Wilkinson C; Faithfull S; Wolstenholme J; Sooriakumaran P; Kastner C; Campbell C; Neal R; Butcher H; Matthews M; Perera R; Rose P BJU Int; 2016 Jun; 117(6B):E10-9. PubMed ID: 25818406 [TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life. Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL; BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448 [TBL] [Abstract][Full Text] [Related]
10. Symptom and function profiles of men with localized prostate cancer. Reeve BB; Tan X; Chen RC; Usinger DS; Pinheiro LC Cancer; 2018 Jul; 124(13):2832-2840. PubMed ID: 29660795 [TBL] [Abstract][Full Text] [Related]
11. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy. Hedgepeth RC; Labo J; Zhang L; Wood DP J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842 [TBL] [Abstract][Full Text] [Related]
12. Plant-based diet associated with better quality of life in prostate cancer survivors. Loeb S; Hua Q; Bauer SR; Kenfield SA; Morgans AK; Chan JM; Van Blarigan EL; Shreves AH; Mucci LA Cancer; 2024 May; 130(9):1618-1628. PubMed ID: 38348508 [TBL] [Abstract][Full Text] [Related]
13. The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. Resnick MJ; Barocas DA; Morgans AK; Phillips SE; Koyama T; Albertsen PC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hoffman KE; Hoffman RM; Kaplan SH; McCollum D; Paddock LE; Stanford JL; Stroup AM; Wu XC; Penson DF Eur Urol; 2015 Jun; 67(6):1019-1025. PubMed ID: 25174325 [TBL] [Abstract][Full Text] [Related]
14. Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study. Downing A; Wright P; Wagland R; Watson E; Kearney T; Mottram R; Allen M; Cairnduff V; McSorley O; Butcher H; Hounsome L; Donnelly C; Selby P; Kind P; Cross W; Catto JW; Huws D; Brewster DH; McNair E; Matheson L; Rivas C; Nayoan J; Horton M; Corner J; Verne J; Gavin A; Glaser AW BMJ Open; 2016 Dec; 6(12):e013555. PubMed ID: 27927667 [TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life by human immunodeficiency virus status in a cross-sectional survey of gay and bisexual prostate cancer survivors. Polter EJ; Wheldon CW; Rosser BRS; Kohli N; Capistrant BD; Kapoor A; Konety B; Mitteldorf D; Ross M; Talley KMC; Terveen L; West W; Wright MM Psychooncology; 2019 Dec; 28(12):2351-2357. PubMed ID: 31518042 [TBL] [Abstract][Full Text] [Related]
16. Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments. Vertosick EA; Vickers AJ; Cowan JE; Broering JM; Carroll PR; Cooperberg MR J Urol; 2017 Sep; 198(3):671-677. PubMed ID: 28342935 [TBL] [Abstract][Full Text] [Related]
17. The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Kopp RP; Marshall LM; Wang PY; Bauer DC; Barrett-Connor E; Parsons JK; Eur Urol; 2013 Oct; 64(4):672-9. PubMed ID: 23587870 [TBL] [Abstract][Full Text] [Related]
18. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. McCammon KA; Kolm P; Main B; Schellhammer PF Urology; 1999 Sep; 54(3):509-16. PubMed ID: 10475363 [TBL] [Abstract][Full Text] [Related]
19. Pain, fatigue and depression symptom cluster in survivors of prostate cancer. Baden M; Lu L; Drummond FJ; Gavin A; Sharp L Support Care Cancer; 2020 Oct; 28(10):4813-4824. PubMed ID: 31980895 [TBL] [Abstract][Full Text] [Related]
20. Achieving Quality Assurance of Prostate Cancer Surgery During Reorganisation of Cancer Services. Cathcart P; Sridhara A; Ramachandran N; Briggs T; Nathan S; Kelly J Eur Urol; 2015 Jul; 68(1):22-9. PubMed ID: 25770482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]